Tieni traccia delle ultime attività di insider trading T2 Biosystems. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni T2 Biosystems.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Sep 17, 2024 | — | -55.00 | $2.42 | -$133.10 | SELL | -68.75% | 25.00 | Sep 13 | ||
Sep 29, 2023 | 10% OWNER | -13.13M | $0.17 | -$2.27M | SELL | -100.00% | 0.00 | Sep 27 - Sep 28 | ||
Sep 28, 2023 | 10% OWNER | -5.39M | $0.20 | -$1.08M | SELL | -60.24% | 3.56M | Sep 26 | ||
Sep 27, 2023 | 10% OWNER | -250.00K | $0.25 | -$62.50K | SELL | -4.74% | 5.02M | Sep 25 | ||
Sep 26, 2023 | 10% OWNER | -5.08M | $0.26 | -$1.31M | SELL | -49.95% | 5.09M | Sep 22 | ||
Sep 25, 2023 | 10% OWNER | -6.34M | $0.30 | -$1.90M | SELL | -49.50% | 6.47M | Sep 21 | ||
Sep 22, 2023 | 10% OWNER | -7.75M | $0.31 | -$2.41M | SELL | -48.65% | 8.18M | Sep 20 | ||
Sep 21, 2023 | 10% OWNER | -10.40M | $0.37 | -$3.81M | SELL | -50.28% | 10.29M | Sep 19 | ||
Apr 06, 2023 | GENERAL COUNSEL | -239.00 | $0.48 | -$114.96 | SELL | -3.49% | 6.61K | Mar 28 | ||
Mar 09, 2023 | CHIEF COMMERCIAL OFFICER | 796.00 | $0.65 | -$349.05 | SELL-OPTIONS | 1768.89% | 841.00 | Feb 20 - Feb 22 | ||
Mar 09, 2023 | CHIEF FINANCIAL OFFICER | 4.22K | $0.62 | -$1.68K | SELL-OPTIONS | 138.53% | 7.27K | Feb 20 - Feb 28 | ||
Mar 09, 2023 | GENERAL COUNSEL | 3.18K | $0.62 | -$2.33K | SELL-OPTIONS | 95.53% | 6.52K | Feb 20 - Feb 28 | ||
Mar 09, 2023 | CHAIRMAN AND CEO | 12.89K | $0.63 | -$6.18K | SELL-OPTIONS | 290.73% | 17.33K | Feb 20 - Feb 28 | ||
Nov 22, 2022 | CHIEF COMMERCIAL OFFICER | 2.04K | $1.79 | -$2.32K | SELL-OPTIONS | 962.74% | 2.25K | Nov 08 - Nov 10 | ||
Apr 11, 2022 | CHAIRMAN, CEO, AND PRESIDENT | 30.00K | $0.50 | $15.00K | BUY | 15.64% | 221.77K | Apr 07 | ||
Apr 11, 2022 | CHIEF OPERATIONS OFFICER | 12.95K | $0.50 | $6.48K | BUY | 7.66% | 181.94K | Apr 08 | ||
Apr 11, 2022 | GENERAL COUNSEL | 10.00K | $0.49 | $4.90K | BUY | 6.38% | 166.65K | Apr 07 | ||
Apr 11, 2022 | CHIEF FINANCIAL OFFICER | 10.00K | $0.48 | $4.77K | BUY | 7.02% | 152.35K | Apr 08 | ||
Apr 11, 2022 | CHIEF COMMERCIAL OFFICER | 10.60K | $0.49 | $5.18K | BUY | ∞ | 10.60K | Apr 08 | ||
Jan 10, 2022 | CHIEF MEDICAL OFFICER | -61.99K | $0.48 | -$29.75K | SELL | -36.55% | 107.61K | Jan 06 | ||
Aug 03, 2021 | 10% OWNER | 5.13K | $0.63 | $4.12K | BUY | 0.12% | 4.20M | Mar 24 - May 20 | ||
Aug 03, 2021 | DIRECTOR | 5.13K | $0.63 | $4.12K | BUY | 0.12% | 4.20M | Mar 24 - May 20 | ||
Jul 02, 2021 | DIRECTOR | -18.18K | $1.16 | -$21.09K | SELL | -3.40% | 516.39K | Jul 01 | ||
Jul 02, 2021 | DIRECTOR | -18.18K | $1.16 | -$21.09K | SELL | -26.34% | 50.85K | Jul 01 | ||
Mar 25, 2021 | GENERAL COUNSEL | 7.91K | $1.56 | -$13.66K | SELL-OPTIONS | 12.10% | 73.26K | Mar 24 - Mar 25 | ||
Mar 18, 2021 | CHIEF OPERATIONS OFFICER | -12.49K | $1.86 | -$23.24K | SELL | -14.38% | 74.42K | Mar 17 | ||
Mar 18, 2021 | CHIEF COMMERCIAL OFFICER | -9.62K | $1.84 | -$17.70K | SELL | -23.33% | 31.61K | Mar 17 | ||
Feb 23, 2021 | GENERAL COUNSEL | 2.72K | $2.06 | -$15.00K | SELL-OPTIONS | 4.34% | 65.35K | Feb 21 - Feb 23 | ||
Feb 23, 2021 | CHIEF FINANCIAL OFFICER | 4.75K | $2.04 | -$10.71K | SELL-OPTIONS | 15.45% | 35.48K | Feb 21 - Feb 23 | ||
Feb 23, 2021 | CHIEF OPERATIONS OFFICER | 2.72K | $2.06 | -$15.00K | SELL-OPTIONS | 4.35% | 65.25K | Feb 21 - Feb 23 |
Sfoglia insider trading su tutte le azioni.